- Investing Ideas
- Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Swedish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Vitrolife
Market Cap: SEK 12.3b
Vitrolife AB (publ) suministra productos de reproducción asistida en Europa, Oriente Medio, África, Asia-Pacífico y América.
VITR
SEK 91.05
7D
-4.9%
1Y
-33.5%
Genovis AB (publ.)
Market Cap: SEK 1.2b
Genovis AB (publ.) desarrolla y vende herramientas para el desarrollo de nuevos métodos de tratamiento y diagnóstico en Norteamérica, Europa y Asia.
GENO
SEK 18.32
7D
-6.4%
1Y
-33.1%
BioGaia
Market Cap: SEK 12.0b
BioGaia AB (publ), empresa del sector sanitario, suministra productos probióticos en todo el mundo.
BIOG B
SEK 118.20
7D
-5.1%
1Y
18.7%